The dependence of CD44 for the versican and HA-mediated effects was confirmed by the inhibition of pericellular matrix formation as well as versican mediated motility and invasion of ovarian cancer cells following treatment with CD44 neutralizing antibody [26]. The gene discussed is CD44; the disease is ovarian carcinoma.